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Abstract—In the high-throughput screening (HTS) campaigns,
the Z’-factor and strictly standardized mean difference (SSMD)
are commonly used to assess the quality of assays and to select
hits. However, these measures are vulnerable to outliers and their
performances are highly sensitive to background distributions.
Here, we propose an alternative measure for assay quality
assessment and hit selection. The proposed method is a non-
parametric generalized variant of SSMD (GSSMD). In this paper,
we have shown that the proposed method provides more robust
and intuitive way of assay quality assessment and hit selection.
Index Terms—Assay quality assessment, Hit selection, Ro-
bustness, Interpretability, Z’-factor, Strictly standardized mean
difference (SSMD), Generalized SSMD (GSSMD)
I. INTRODUCTION
In high-throughput screening, hundreds to tens of millions
[1] single measurements of test samples are often compared to
positive and negative control to characterize the effectiveness
of the treatment. For instance, in a typical drug screening,
luminescence-based cell viability assays can be used to test
the cytotoxic effects of compounds in comparison to known
drugs and biological inerts. Since the performance of the assay
is assessed retrospectively, the assay developer must measure
the identifiability and reproducibility of the assay to determine
the appropriate one from the candidates before conducting
the actual HTS campaign [2]. Within an acceptable assay,
assay developer also need to set the threshold of acceptance
according to the quality of the assay.
Quality metrics such as Z’-factor [3] and strictly standard-
ized mean difference (SSMD) [4] have been used for this
purpose, but these quality measures have several limitations,
e.g., sensitivity to measurement noise etc. Only statistical pa-
rameters such as the mean and variance of the distribution are
taken into account, which makes them vulnerable to outliers
in the measurement. In addition, since infinite scale ranges of
these measures are generally not intuitive for most biologists
[5], it can be complicated to choose suitable thresholds for
various types of experiments and it is not easy to understand
the meaning of these values without referring to the literature.
These disadvantages limit the applicability of these measures.
To address aforementioned issues, we propose a non-
parametric generalized variant of strictly standardized mean
difference (GSSMD). The proposed GSSMD is inspired by a
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recently proposed contrast measure [6] for ultrasound imaging
systems. GSSMD is defined using the overlap between two
distributions. Thus, it avoids the complexity of Z’-factor and
SSMD calculations in non-standard or transformed distri-
butions. By definition, it is intuitive enough and easy to
interpret. In this paper, we used simulations and real biological
data sets to support our claims. Mathematical definitions and
experimental results are described in the following sections.
II. BACKGROUND
A. Conventional measure of assay quality
Classic indicators of assay quality are the signal-to-noise
ratio (SNR) and the signal-to-background ratio (SBR) [2].
The SNR and SBR are defined as S/N = (µ1 − µ2)/σ2 and
S/B = µ1/µ2 where µ and σ are the mean and variance of
the distribution. The more recently proposed metric is called
Z’-factor [3] and has been proposed to provide a better metric
considering the dynamic range of measurement. The Z’-factor
is defined as:
Z ′f = 1−
3(σ1 + σ2)
|µ1 − µ2| (1)
One major drawback of the Z’-factor comes from the normal
distribution assumption behind it. Because of this assumption,
it is often too strict for many biological assays that are fully
functional but do not follow normal distribution. Moreover,
Z’-factor is difficult to interpret due to the imbalanced range
given by −∞ ≤ Z ′f ≤ 1.
A slightly improved metric for assay quality is SSMD [4]
which has been proposed to solve the problem of Z’-factor
mentioned above. The SSMD is defined as:
SSMD =
µ1 − µ2√
σ21 + σ
2
2
(2)
Although SSMD resolves some of the issues of Z’-factor
such as unbalanced range and too strict thresholds but is
still sensitive to the types of distribution and distribution
transformations. Also, similar to Z’-factor, an infinite range
of SSMD (−∞ ≤ SSMD ≤ ∞) makes it difficult to set the
correct criteria for each assay.
B. Contrast-to-noise ratio and its relationship with assay
quality measures
The quality of assay can be defined as the contrast between
two sets of measurements. If two sets of measurements are
significantly different from each other, we can say that the
given measurements are obtained from high quality assay.
Interestingly, this contrast-based quality assessment is widely
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2used for medical imaging, and similar metrics are proposed for
relatively similar tasks. For example, in the field of ultrasound
imaging, the contrast of intensity in two regions of interest
is used for the identification of anatomical structures and
associated abnormalities or diseases. A widely used measure
of contrast is contrast-to-noise ratio (CNR) [6]. The formula
of CNR is shown below.
CNR = |SSMD| = |µ1 − µ2|√
σ21 + σ
2
2
(3)
where µ and σ are the mean and variance of the intensities in
two regions.
From the above equations (2) and (3), it is easy to see
that the CNR measure is very similar to the SSMD. The
only difference is that the CNR is suitable magnitude of the
change only, while SSMD considers both the direction and the
magnitude of the change.
The CNR has two major limitations. First, it is sensitive
to distribution transformations. Therefore, a high CNR values
does not mean high detectability especially if underlying
distributions are different. Second, it is not intuitive because
the range of scale is infinite [6]. These are the same limitations
as SSMD we mentioned earlier.
C. Proposed generalized variant of SSMD (GSSMD)
Recently, to address limitations of CNR, a generalized
variant of CNR called GCNR is proposed [6]. It is defined
as:
OVL =
∫
min{p1(x), p2(x)}dx (4)
GCNR = 1− OVL
where OVL is the overlap of two probability density functions
(PDFs) p1(x) and p2(x). The range of overlap is 0 ≤ OVL ≤
1.
GCNR is intuitively defined as non-overlapping proportion
between two PDFs. In addition, unlike CNR or SSMD, GCNR
is less susceptible to distribution transforms because there is
no underlying assumption about the distribution. In practice,
the PDFs of positive and negative control samples can be
estimated non-parametrically by histogram with an appropriate
bin size, depending on the number of samples [7].
Inspired by GCNR, here we propose generalized variant
of SSMD (GSSMD) to address similar problems in the field
of assay development. As in the case of SSMD and CNR,
the proposed GSSMD is similar to GCNR, but unlike GCNR
where only the size of the overlap area is taken into account,
GSSMD also considers the direction of overlap. Mathemati-
cally the GSSMD is defined by the formula shown below.
GSSMD = sgn(µ1 − µ2)× (1− OVL) (5)
where sgn[.] is sign operator and the GSSMD is in the range
−1 ≤ GSSMD ≤ 1.
The following sections describe the performance and effec-
tiveness of the proposed method using simulations and real
biological experiment data.
III. RESULTS
In this study, Z’-factor, SSMD and GSSMD are compared
in simulation and real biological experimental data set. For the
simulation setup, different configurations are selected for the
distribution of positive and negative samples, each of which
mimics a specific case of study. For experimental data set,
we considered RNAi screening of cell viability in Drosophila
Kc167 cells [8] as a case study. For all experiments, to estimate
the histogram, we used 1+log2(N) number of bins [7], where
N is the number of samples.
A. Simulations
In our hypothetical experimental setup, we compared per-
formance and interpretability of the Z’-factor and SSMD with
proposed GSSMD in different cases. We studied the relation-
ship between the mean difference of the two distributions
and the calculated value of each measure. We focused on
normal distributions with equal variances and then we looked
at the log-normal distributions that are often observed in
biological systems [9]. We also identified the effect of outliers
on measurements derived from known mean and variance
of the normal distribution. To account for various types of
measurement noise, we investigated the effect of additive white
Gaussian noise on sampled data. We compared SSMD and
GSSMD at different noise levels controlled by the signal-to-
noise-ratio (SNRmeasurement) of the measurement. Finally, to
set the lower bound of GSSMD from the variances associated
with non-parametric estimation of PDFs, we examined the
effect of sample number on GSSMD calculations.
1) Normal distribution with equal variance: In this experi-
ment, three cases were selected for the distribution of negative
control samples. In particular, for the distribution of negative
control samples the mean is assumed to be zero µ = 0 in
all three cases, but the variance changes to σ = 1, 3 and
5 (see Figure1). We generated 21 positive control sample
distributions drawn from N (µ, σ) where µ = 0, 1, 3, 5, 10, 20,
and 30 and σ = 1, 3 and 5. Figure 1., show the distribution
and histogram of each case for each measure. In the Figure 1.,
GSSMD increases as the mean difference increases and it
decreases as the variance of the distribution increases. Note
that in Figure 1.(A), GSSMD is maximum (i.e., equals to
one) with mean difference of 10 (yellow curve), so there
is no overlap between the two distributions. In other cases
(see Figure 1(B and C)) due to an increase in distribution
variance, the value gradually decreases, indicating an increase
in overlap. On the other hand, the values of Z’-factor and
SSMD change dramatically and do not mean anything by
themselves. In addition, GSSMD exhibits the highest sensi-
tivity in terms of acceptable levels of assay quality, which is
set at 0.95 to indicate 5% overlap between the positive and
negative control distributions. The acceptable quality scores of
Z’-factor and SSMD are 0.5 and 3, referenced in Zhang [3],
[4]. Although Z’-factor or SSMD can be applied to measure
effect size of large differences, in many real data sets there is
no clear separation, as shown in the Figure 1.(A), so GSSMD
is practically better suited as a quality assessment method.
This is further evaluated in later sections.
3Fig. 1. GSSMD provided interpretable and reliable statistical difference estimate in the ideal simulation setup (σc = 1, 3, 5 , n = 1, 000 in (A), (B), and
(C) respectively). The numbers in red in the table represent values that have exceeded acceptable quality thresholds for the assay, according to the Zhang [3],
[4], excluding GSSMD. Here we set the threshold for GSSMD to GSSMD = 0.95 which represents a 5% overlap between the two distributions. Bg Dist. =
Background Distribution, Tg Distributions = Target Distributions.
Fig. 2. Performance of each measure in log-normal distribution setup (σ = 0.5). The acceptable values are > 0.5, > 3, and > 0.95 respectively.
42) Log-normal distribution with equal variance: We also
compared each measure with the non-normal distribution
setting. For this purpose, log-normal distribution was chosen
because the data obtained from biological experiments often
follow the log-normal distribution [9]. The recommended
acceptable thresholds for Z’-factor, SSMD and GSSMD are
0.5 [3], 3 [4], and 0.95 respectively. As you can see in the
Figure 2., GSSMD can effectively detect the difference be-
tween the two distributions when mean difference is µdiff =
µ1 − µ2 = 3.0, and variance is σ = 0.5, contrary other
measures did not detect any difference in acceptable assay
quality for any given configuration.
3) Effect of outliers: Unlike simulation, real experimental
measurements are prone to noise and outliers. To simulate the
effect of outliers, we replaced some positive samples in the
original sample set with outlier samples which are obtained
from an independent normal distribution. The original sample
set consist of Nt = 2000 samples, (N = 1, 000) in each class
(positive and negative). Both the positive and negative samples
are drawn from the identical normal distributions (N (0, 1)).
Since two distributions are identical therefore the expected
GSSMD = 0.
In particular in this experiment the outliers effect is sim-
ulated by replacing positive samples with outlier samples
drawn from six different normal distributions. The outliers are
generated using N (µ, σ), where the variance σ = 1 for all
distributions and the mean values are µ = 1, 3, 5, 10, 20 and
30. For each case, 1, 000 positive and negative samples were
generated and 0 −→ 30% positive samples were replaced with
outlier samples.
Figure 3. shows the effect of outliers on three measures,
where the blue, green and red dots represent Z’-factor, SSMD
and GSSMD respectively. In the subplot, we can see that when
we increase the proportion and mean values of the outliers, the
Z’-factor changes sharply and its absolute value become ∼ 18
times smaller than outlier free condition.
GSSMD, on the other hand, converges to the percentage
of outliers. Especially when the mean of outlier samples is
greater than 5. In comparison to Z’-factor, SSMD measure is
relatively insensitive to outliers and approaches to a specific
value when the mean of outlier samples is greater than 10.
However, the values of SSMD has no intuitive meaning. Thus,
GSSMD is the most sensitive measure for detecting outliers at
small mean differences and the values have intuitive meaning,
indicating the percentage of outliers.
4) Effect of signal-to-noise-ratio (SNR): There is other
types of noise associated with measurement inconsistency.
This type of noise is modeled as Gaussian noise (N ) with
different level of SNR. Here the term SNR is different from
assay quality metric mentioned earlier, which is given as
SNRassay = (µ1 − µ2)/σ2. The SNR of measurement is de-
fined as the logarithm of the power ratio, SNRmeasurement =
10× log10(Psignal/Pnoise). We used MATLAB built-in func-
tion awgn to add white Gaussian noise into our simulated
measurement signal. Here the background signal is defined as
a randomly sampled data points drawn from N (0, 1) and the
target signal is defined as background signal + defined mean
difference. We added white Gaussian noise independently for
each signal and calculate SSMD and GSSMD to clarify the
difference between two measures in terms of measurement
signal-to-noise ratio.
Figure 4(A). show estimated SSMD and GSSMD at dif-
ferent noise levels and mean differences. Here the number
of samples is quite large (N = 1, 000, 000). As you can
see, SSMD scale varies when the mean difference increases
however GSSMD range doesn’t changes. GSSMD represent
non-overlap proportion by definition, it is always from -1 to 1
but we only consider positive mean difference in this example,
so it changes from 0 to 1. Figure 4.(B), shows scaled version
of figure 4.(A), to clarify the difference between SSMD and
GSSMD. The blue line represents GSSMD and the red line
represents SSMD. If there is no mean difference, compared to
SSMD, the GSSMD due to the stochastic nature of sampling
exhibits high fluctuation, especially in the region of low SNR.
The value range for GSSMD is about ±0.003 but here we
adjusted it from 0 to 1 to compare it with other conditions.
However this fluctuation decreases with increasing SNR. If the
mean difference between the two distributions is equal to one,
GSSMD has the same sensitivity as SSMD. In other cases
where the mean difference between the two distributions is
larger, the sensitivity of GSSMD to SNR is greater than that
of SSMD.
One important aspect of quality metric is the sensitivity to
the number of measurement samples. Here we investigated the
effect of sample size as shown in the Figure 4.(C). Each line
in the subplot of Figure 4.(C), represents different effect size
(µdiff = 0, 1, 3, 5, 10, 20 and 30). The x and y-axes of the
plot represent the SNR in the deci-Bell (dB) scale and the
measured SSMD and GSSMD values respectively.
For further validation, the effect of smaller sample sizes
was investigated. Figure 5.(A), shows the trend of SSMD and
GSSMD at different noise levels and the mean differences.
Here we performed the same experiment as in Figure 4.(A),
and (B), with fewer number of samples (N = 100). Fig-
ure 5.(B), show scaled version of Figure 5.(A). As expected,
the decrease in the number of samples caused the SSMD
and GSSMD to fluctuate due to the uncertainty in the PDF
estimation. However, the GSSMD has better resolution than
SSMD even with this small sample number.
In Figure 5.(C), we showed that the GSSMD can be
applicable to even smaller number samples i.e., (N ≤ 100).
Although N ≤ 10 is very small for HTS setting however,
in lab scale settings we often observe small samples size
i.e., ' 10 samples for one condition. The calculated GSSMD
does not produce meaningful results in the low SNR region
of N ≤ 10. This situation can be handled with the sub-
sampling technique shown in Figure 5.(D). Here, we combined
n = 10 independent batch experiments with N = 10 samples
each (Ntotal = 100 total) and measure each metric based
on N = 10 samples (n = 10) times of sub-sampling. We
used N = 10 data points to estimate SSMD and GSSMD for
each sub-sampling and showed the average results. The results
showed similar power as 1 independent batch experiment with
100 samples.
5) Lower bound estimation for worst case scenario: Since
GSSMD is a non-parametric measure, the value of GSSMD
5Fig. 3. GSSMD is relatively insensitive to outliers compared to Z’-factor and SSMD. Blue, green and red dots represent Z’-factor, SSMD and GSSMD
respectively.
Fig. 4. GSSMD is better quality metric for the noisy data sets. (A) The range of SSMD increases with the mean difference, so the meaning of the values
can vary depending on the mean difference. Unlike SSMD, GSSMD is limited from 0 to 1 (in case of positive overlap), so the meaning of the value is not
affected by the mean difference. (B) Scaled plot for each measure. GSSMD is more sensitive when the mean difference is large. Here we scaled the value
from 0 to 1. (C) SSMD and GSSMD with various sample sizes, noise levels and mean difference. GSSMD identifies mean differences even in the high noise
regions. x-axis represents SNR in deci-Bell (dB) scale for all figures.
6Fig. 5. GSSMD can be used for small and noisy data sets. (N ¡ 100) (A) SSMD and GSSMD with sample size 100. The curve is little noisier but the trend is
maintained. (B) Scaled plot for each measure. GSSMD is more sensitive when the mean difference is large, as shown in the figure 4 (B). Here, we adjusted
the value from 0 to 1 too. (C) SSMD and GSSMD with sample size less than 100. The signal is too deformed to distinguish mean difference when N = 10.
(D) GSSMD and SSMD estimation using resampling. GSSMD and SSMD can be estimated by sampling 10 of the 100 samples. (10 runs) The sensitivity of
GSSMD is slightly reduced but still better than SSMD.
may not always be zero if there is no mean difference between
the two PDFs. This is true because the accuracy and stability of
GSSMD metric depends on the number of samples used in the
estimation of two PDFs. Therefore, we decided to investigate
lower bound of GSSMD measure when there is a complete
overlap between the two PDFs (the worst-case scenario).
In this experiment, we estimated the lower-bound of
GSSMD for two sample sets. In particular, we tested normal
and log-normal distribution cases both with µ = 0 and σ = 1.
Theoretically, the expected GSSMD value for both scenarios is
0, but some variation in the expected value might occur due to
the variations in estimation of PDFs. Therefore, we performed
an 10, 000 independent trials and calculated the mean, variance
and extreme values of GSSMD for each sample size.
Figure 6. show the estimated GSSMD for various sample
size (N = 3 −→ 106). As expected, as the sample size increase,
the mean and variance of the estimated GSSMD decrease. We
also found that the shape of distributions of estimated GSSMD
with the sample size of more than 100 is stabilized. The lower-
bound of GSSMD for a specific sample size can be seen in
the figure. Here we showed only normal distribution case, but
the overall behavior is quite similar for both distributions (see:
https://github.com/psychemistz/gssmd).
For log-normal distribution the lower-bound is even smaller
than the normal distribution case, however for simplicity
one can choose the maximum of the normal distribution to
avoid possible false positives. This robust and intuitive nature
of GSSMD measure make it a suitable choice for reliable
assessment of assay quality. To reject this null hypothesis,
throughout our simulation study, we chose 5% as the threshold
of GSSMD for sample size N = 1, 000.
B. Case study of RNAi screening using real experiment data
For the case study, we selected RNAi screening of cell
viability in Drosophila Kc167 cells [8]. We used the dataset
provided by cellHTS2 R package [10]. In RNAi screening
experiment HTS of 19, 470 dsRNAs was performed in Kc167
cells to characterize Drosophila genes, which are related to
cell growth and viability. For every well of each plate, the
authors introduced RNAi of different genes and measured cell
viability through Luciferase activity.
In other words, when targeted binding of specific RNAi
promotes a decrease in cell viability, Luciferase activity was
reduced according to the cell viability. The Figure 7. shows the
calculated measures on the dataset, where red dots represent
negative controls (GFP, Rho, no RNAi treatment) and blue dots
represent positive controls (RNAi for D-IAP1 which inducing
time-depedent cell death in Drosophila Kc167 cells). Grey dots
are samples treated with RNAi, and it is not known how much
reduction in cell viability indicates targeted RNAi binding.
Like Z’-factor and SSMD, the proposed GSSMD can also
be used to identify thresholds for hit selection. In order
to evaluate performance of each measure for finding the
correct threshold of hit selection, we trained logistic regression
classifier based on positive and negative control samples.
The logistic regression class separation boundary is used a
reference for optimal threshold of Luciferase activity. We
trained the logistic regression classifier on the first plate of
7Fig. 6. GSSMD score for overlapping distributions, effect of sample-size and lower bound for reliable screening. (A) Violin plot of GSSMD range -1 to 1,
(B) Violin plot of GSSMD with matched scale.
the replicated experiment, and tested it on the second plate.
The threshold provided by the optimal logistic regression
classifier (accuracy = 0.956, type I error = 0.018) was similar
to the GSSMD threshold (5% overlap), but the recommended
thresholds based on the Z’-factor and SSMD were either too
strict or too loose. Such strict or loose thresholds can result
in the loss of many functional targets or in too many false
positives, as clearly demonstrated in this example.
Fig. 7. GSSMD can be used to find hit thresholds in RNAi screening. We set
the GSSMD threshold to a point where the overlap of the two distributions
is less than 5%. GSSMD threshold was similar to the threshold of optimal
logistic regression classifier (Accuracy = 0.956, Type I error = 0.018) but the
recommended threshold based on Z’-factor and SSMD were either too strict
or too loose to identify the actual hit.
IV. DISCUSSION
Bio-assay quality assessment and threshold setting for the
hit selection are routinely performed in academia and in-
dustrial environments, where a large number of single mea-
surements are performed. Recent advances in biotechnology
have enabled new types of large scale experimental assays
including but not limited to CRISPR-Cas9 [11] screening
and cell painting [12]. However, current measures like Z’-
factor and SSMD are designed to assess the quality of high-
throughput chemicals and RNAi screening and rely heavily
on normal distribution assumption. Therefore, it is not clear
whether these measures can be applied to detect useful hits in
newly developed assays with sufficient sensitivity.
Also, as described in the case study, Z’-factor or SSMD
may be too strict or too loose to be suitable for selection
thresholds for hits even in experiments for which the metrics
are designed. In addition, the thresholds of these measures
have no intuitive meaning so we can not possibly set the
correct thresholds for the experiments without referring similar
experiments in the literature. However, due to the inherent
variability of biological system, such as genetic and transcrip-
tional change from unknown sources [13], even when the same
experiment performed with the same cell type, the threshold
provided in the literature may not be appropriate.
In contrast, the proposed GSSMD measure is relatively
sensitive to detect changes in biological assays. It is also
robust against outliers and measurement noise, as described in
simulation studies. Non-parametric characteristics may cause
8deviations in the estimates of the measurements, but we have
shown that the appropriate number of samples and bin size
can minimize this variability. In addition to this performance
issue, GSSMD also showed the desired characteristics of the
assay quality metric, i.e., interpretability. By definition, it is
a measure of non-overlaping proportion of two distributions,
so we can control lower bound of false positive rate of
an assay through GSSMD threshold. Both performance and
interpretability of GSSMD make it an attractive alternative to
other assay quality and threshold selection methods.
V. CONCLUSION
In this paper, we presented new assay quality metric called
GSSMD. We showed that GSSMD may have advantages
compare to the conventional quality control measures such as
Z’-factor and SSMD based on simulation and real biological
assay data set. We believe that the proposed method can
be easily implemented in current HTS setup and medium
throughput experimental setup.
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